cross-sectional·pediatrics, clinical trial, epidemiology, observational study, public health·PMC10617051
Medication errors related to high-alert medications in a paediatric university hospital – a cross-sectional study analysing error reporting system data
BMC Pediatrics · 4 authors, 3 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This cross-sectional study analyzed self-reported medication errors at a paediatric hospital from 2018-2020. It found that errors involving high-alert medications were more likely to cause patient harm and have a higher risk classification than errors involving other drugs.
Full summary
730 CHARS
This study analyzed 2,132 self-reported medication error (ME) reports from a paediatric university hospital. The study found that 34.8% (n=743) of error reports involved high-alert medications (n=872 unique medications). A majority (73%) were administered intravenously, and 6% of IV preparations were given via off-label routes. Statistical analysis showed that any degree of patient harm and the highest risk classifications (IV-V) were significantly more likely to be associated with errors involving high-alert medications compared to errors with other drugs. Limitations include potential underreporting and the fact that the study material consisted of self-reported errors, which may skew the representation of error types.
